Clinical Trial Detail

NCT ID NCT01321346
Title A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Therapeutic Advances in Childhood Leukemia Consortium
Indications

acute myeloid leukemia

non-Hodgkin lymphoma

acute lymphoblastic leukemia

Therapies

Cytarabine

Panobinostat

Age Groups: child

No variant requirements are available.